— Know what they know.
Not Investment Advice

MNPR NASDAQ

Monopar Therapeutics Inc.
1W: +2.8% 1M: +17.6% 3M: +13.1% YTD: -5.0% 1Y: +69.9% 3Y: +1371.4% 5Y: +145.3%
$63.12
+0.44 (+0.70%)
 
Weekly Expected Move ±9.6%
$48 $54 $59 $65 $71
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 60 · $422.8M mcap · 4M float · 4.58% daily turnover · Short 74% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
28.4 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -0.0%  ·  5Y Avg: 0.0%
Cost Advantage
33
Intangibles
25
Switching Cost
38
Network Effect
18
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MNPR has No discernible competitive edge (28.4/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -0.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$104
Avg Target
$104
High
Based on 12 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$103.83
Analysts12
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-01-09 Morgan Stanley Maxwell Skor Initiated $115 +81.4% $63.40
2025-11-14 Raymond James Chris Raymond $142 $123 -19 +41.4% $87.01
2025-10-13 Barclays Etzer Darout Initiated $125 +42.3% $87.82
2025-10-06 Raymond James $80 $142 +62 +42.9% $99.39
2025-10-02 Oppenheimer Initiated $115 +35.7% $84.73
2025-09-29 H.C. Wainwright $70 $105 +35 +37.0% $76.63
2025-09-25 Chardan Capital Keay Nakae Initiated $85 +16.9% $72.69
2025-09-25 Piper Sandler Biren Amin Initiated $95 +30.7% $72.69
2025-09-24 BTIG $87 $104 +17 +42.4% $73.04
2025-09-09 BTIG Jeet Mukherjee Initiated $87 +93.6% $44.93
2025-09-02 Raymond James Initiated $80 +135.8% $33.93
2025-08-26 H.C. Wainwright $22 $70 +48 +128.7% $30.61
2024-11-19 UBS Justin Walsh Initiated $37 +94.6% $19.01
2024-11-11 H.C. Wainwright Sean Lee Initiated $22 +39.2% $15.81

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
4
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MNPR receives an overall rating of B-. Strongest factors: D/E (4/5), P/B (5/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-04 C+ B-
2026-04-30 B- C+
2026-04-22 C+ B-
2026-04-01 B- C+
2026-03-30 C B-
2026-03-27 C+ C
2026-01-03 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
85
Earnings Quality
70
Growth
Value
42
Momentum
Safety
15
Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.38
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
Ohlson O-Score
-12.78
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 48.8/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.67x
Accruals: -0.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MNPR scores 0.38, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MNPR scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MNPR's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MNPR receives an estimated rating of BB+ (score: 48.8/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-35.95x
PEG
1.27x
P/S
0.00x
P/B
0.00x
P/FCF
-46.71x
P/OCF
EV/EBITDA
3544.02x
EV/Revenue
EV/EBIT
3544.02x
EV/FCF
6113.84x
Earnings Yield
-3.20%
FCF Yield
-2.14%
Shareholder Yield
7.48%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MNPR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.868
EBT / EBIT
×
EBIT Margin
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.021
Assets / Equity
=
ROE
-0.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MNPR's ROE of -0.0% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1614 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$63.12
Median 1Y
$22.77
5th Pctile
$2.86
95th Pctile
$188.50
Ann. Volatility
134.8%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Chandler D. Robinson,
MD Chief Executive Officer and Director
$700,000 $6,263,958 $10,637,821
Andrew Cittadine Operating
rating Officer
$440,000 $2,343,427 $4,706,431
Quan Vu Financial
ancial Officer, Secretary, and Treasurer
$305,000 $746,186 $2,101,314

CEO Pay Ratio

0:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,637,821
Avg Employee Cost (SGA/emp): $309,099,545
Employees: 22

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
22
+37.5% YoY
Revenue / Employee
Profit / Employee
$-623,495
NI: $-13,716,894
SGA / Employee
$309,099,545
Avg labor cost proxy
R&D / Employee
$450,192,045
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -54.6% -60.4% -52.6% -55.9% -59.8% -59.5% -72.4% -72.3% -68.4% -65.3% -1.1% -97.1% -90.9% -82.6% -51.4% -54.7% -57.1% -64.1% -0.0% -0.0% -0.02%
ROA -51.2% -56.6% -48.7% -51.8% -55.4% -55.1% -62.3% -62.2% -58.9% -56.2% -81.7% -74.0% -69.3% -62.9% -46.1% -49.0% -51.2% -57.5% -0.0% -0.0% -0.02%
ROIC 6.0% 6.6% 5.3% 5.6% 6.0% 6.0% 2.8% 2.8% 2.7% 2.6% 4.2% 3.8% 3.5% 3.3% 2.5% 2.7% 2.9% 3.3% -0.0% -0.0% -0.02%
ROCE -50.3% -55.5% -48.2% -51.2% -54.7% -54.4% -1.0% -1.1% -1.0% -97.3% -1.6% -1.4% -1.3% -1.2% -28.6% -31.3% -32.5% -36.4% -0.0% -0.0% -0.01%
Gross Margin
Operating Margin
Net Margin
EBITDA Margin
FCF Margin
OCF Margin
ROE 3Y Avg snapshot only -55.43%
ROE 5Y Avg snapshot only -64.28%
ROA 3Y Avg snapshot only -43.69%
ROIC Economic snapshot only -0.01%
Cash ROA snapshot only -0.01%
Cash ROIC snapshot only -0.01%
CROIC snapshot only -0.01%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -47.88 -35.83 -22.19 -16.61 -14.02 -9.41 -14.59 -8.68 -5.78 -4.61 -3.02 -7.16 -5.88 -11.95 -16.21 -15.35 -14.47 -29.93 -31.86 -31.21 -35.951
P/S Ratio 0.000
P/B Ratio 23.59 19.53 10.66 8.48 7.67 5.12 15.21 9.03 5.69 4.34 4.53 9.75 7.50 13.85 4.59 4.62 4.55 10.57 0.00 0.00 0.004
P/FCF -62.90 -46.95 -27.60 -20.48 -18.85 -12.25 -21.35 -13.03 -7.34 -5.75 -3.22 -7.52 -6.15 -13.00 -39.45 -24.43 -25.52 -53.72 -35.82 -46.71 -46.708
P/OCF
EV/EBITDA -62.72 -72.65 -45.56 -30.86 -23.94 -10.05 -18.39 -10.13 -6.11 -4.43 -2.61 -7.72 -6.21 -14.56 -12.22 -11.26 -10.62 -26.03 4011.07 3544.02 3544.024
EV/Revenue
EV/EBIT -44.76 -33.27 -19.90 -14.49 -12.06 -7.43 -13.32 -7.35 -4.36 -3.12 -2.05 -5.88 -4.63 -10.42 -12.22 -11.26 -10.62 -26.03 4011.07 3544.02 3544.024
EV/FCF -60.06 -44.38 -24.82 -17.89 -16.21 -9.68 -19.53 -11.16 -5.67 -4.03 -2.30 -6.52 -5.08 -11.78 -30.05 -18.65 -19.38 -48.16 5019.28 6113.84 6113.837
Earnings Yield -2.1% -2.8% -4.5% -6.0% -7.1% -10.6% -6.9% -11.5% -17.3% -21.7% -33.2% -14.0% -17.0% -8.4% -6.2% -6.5% -6.9% -3.3% -3.1% -3.2% -3.20%
FCF Yield -1.6% -2.1% -3.6% -4.9% -5.3% -8.2% -4.7% -7.7% -13.6% -17.4% -31.0% -13.3% -16.3% -7.7% -2.5% -4.1% -3.9% -1.9% -2.8% -2.1% -2.14%
PEG Ratio snapshot only 1.275
Price/Tangible Book snapshot only 0.003
Shareholder Yield snapshot only 7.48%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 14.28 14.28 12.98 12.98 12.98 12.98 4.21 4.21 4.21 4.21 4.17 4.17 4.17 4.17 11.47 11.47 11.47 11.47 51.35 51.35 51.353
Quick Ratio 14.28 14.28 12.98 12.98 12.98 12.98 4.21 4.21 4.21 4.21 4.17 4.17 4.17 4.17 11.47 11.47 11.47 11.47 51.35 51.35 51.353
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.001
Net Debt/Equity -1.07 -1.07 -1.07 -1.07 -1.07 -1.07 -1.30 -1.30 -1.30 -1.30 -1.30 -1.30 -1.30 -1.30 -1.09 -1.09 -1.09 -1.09 -0.45 -0.45 -0.448
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.001
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -10.15 -8.97 -8.970
Net Debt/EBITDA 2.97 4.20 5.09 4.46 3.89 2.66 1.72 1.70 1.81 1.89 1.05 1.19 1.30 1.51 3.82 3.49 3.36 3.00 4039.69 3571.10 3571.100
Interest Coverage
Equity Multiplier 1.07 1.07 1.08 1.08 1.08 1.08 1.31 1.31 1.31 1.31 1.31 1.31 1.31 1.31 1.10 1.10 1.10 1.10 1.02 1.02 1.021
Cash Ratio snapshot only 22.606
Cash to Debt snapshot only 399.132
FCF to Debt snapshot only -0.065
Defensive Interval snapshot only 1206405.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover
Receivables Turnover
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
DSO
DIO
DPO
Cash Conversion Cycle
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue
Net Income -1.1% -58.9% -44.4% -36.3% -34.0% -20.5% -15.5% -8.4% 4.1% 7.9% 20.1% 27.5% 28.3% 31.7% -85.5% -1.2% -1.4% -2.0% 12.0% 9.6% 9.57%
EPS -75.0% -40.3% -27.6% -31.3% -33.3% -18.8% -12.3% -4.3% 9.8% 16.8% 30.6% 40.5% 16.2% 16.1% -1.4% -4.0% -3.0% -3.8% -51.0% 26.0% 25.97%
FCF -1.1% -59.6% -56.9% -43.3% -31.0% -21.3% 1.8% 10.9% -1.5% 3.8% -9.4% -3.6% 12.8% 21.8% 18.5% -43.8% -43.9% -82.0% -90.5% 3.8% 3.84%
EBITDA -49.8% 26.3% 5.1% 9.1% 7.4% -91.3% -91.3% -69.2% -39.1% 9.3% 9.3% 20.5% 23.2% 30.4% -1.3% -1.8% -2.2% -3.2% 3.0% -0.2% -0.18%
Op. Income -1.1% -59.1% -40.2% -33.3% -31.2% -18.4% -15.4% -9.4% 1.8% 4.7% 16.2% 24.3% 26.3% 28.8% -83.0% -1.2% -1.6% -2.1% -3.4% -5.9% -5.93%
OCF Growth snapshot only 3.84%
Asset Growth snapshot only 2332.97%
Equity Growth snapshot only 2503.28%
Shares Change snapshot only 22.16%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -0.3% -0.3% -0.3% -0.3% -24.2% -24.2% -24.2% -24.2% 43.2% 43.2% 43.2% 43.2% 21.0% 21.0% 20.99%
Assets 5Y 35.2% 35.2% 35.2% 35.2% 5.1% 5.1% 5.08%
Equity 3Y -7.2% -7.2% -7.2% -7.2% -29.1% -29.1% -29.1% -29.1% 42.7% 42.7% 42.7% 42.7% 22.9% 22.9% 22.90%
Book Value 3Y -13.2% -13.5% -14.1% -14.3% -35.7% -35.3% -27.0% -26.9% 47.1% 73.7% 73.7% 73.3% 28.8% 26.6% 26.58%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earnings Stability 0.97 0.97 0.99 0.97 0.93 0.90 0.82 0.71 0.66 0.48 0.29 0.06 0.80 0.70 0.59 0.46 0.70 0.62 0.619
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.82 0.85 0.86 0.92 0.94 0.97 0.98 0.97 0.92 0.89 0.89 0.87 0.50 0.50 0.50 0.50 0.95 0.96 0.962
Earnings Smoothness
ROE Trend -0.23 -0.19 -0.15 -0.06 -0.60 -0.56 -0.46 -0.40 -0.74 -0.59 -0.51 -0.42 0.99 0.90 0.82 0.70 0.89 0.83 0.831
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.76 0.76 0.80 0.81 0.74 0.77 0.68 0.67 0.79 0.80 0.94 0.95 0.96 0.92 0.41 0.63 0.57 0.56 0.89 0.67 0.668
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.668
CapEx/Revenue
Accruals Ratio -0.12 -0.13 -0.10 -0.10 -0.14 -0.13 -0.20 -0.21 -0.12 -0.11 -0.05 -0.04 -0.03 -0.05 -0.27 -0.18 -0.22 -0.25 -0.00 -0.00 -0.000
Sloan Accruals snapshot only 1.956
Cash Flow Adequacy snapshot only -3337293.667
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 6.0% 8.0% 7.5% 7.48%
Net Buyback Yield -4.8% -3.6% -5.4% 0.0% 0.0% -0.0% -0.1% -1.0% -2.8% -4.3% -8.2% -8.2% -9.0% -4.5% -23.5% -22.1% -22.4% -25.6% -21.2% -19.8% -19.82%
Total Shareholder Return -4.8% -3.6% -5.4% 0.0% 0.0% -0.0% -0.1% -1.0% -2.8% -4.3% -8.2% -8.2% -9.0% -4.5% -23.5% -22.1% -22.4% -25.6% -21.2% -19.8% -19.82%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 0.98 1.00 1.00 1.00 1.00 1.00 0.99 0.98 0.97 0.95 0.95 0.95 0.96 0.99 0.96 0.97 0.97 0.90 0.87 0.868
EBIT Margin
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.07 1.07 1.08 1.08 1.08 1.08 1.16 1.16 1.16 1.16 1.31 1.31 1.31 1.31 1.12 1.12 1.12 1.12 1.02 1.02 1.021
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.62 $-0.68 $-0.72 $-0.77 $-0.82 $-0.81 $-0.81 $-0.80 $-0.74 $-0.67 $-0.56 $-0.48 $-0.62 $-0.56 $-1.36 $-2.37 $-2.47 $-2.73 $-2.05 $-1.76 $-1.76
Book Value/Share $1.25 $1.25 $1.51 $1.50 $1.50 $1.48 $0.78 $0.77 $0.75 $0.71 $0.37 $0.35 $0.49 $0.49 $4.79 $7.88 $7.86 $7.73 $20595.44 $16148.51 $15863.43
Tangible Book/Share $1.25 $1.25 $1.51 $1.50 $1.50 $1.48 $0.78 $0.77 $0.75 $0.71 $0.37 $0.35 $0.49 $0.49 $4.79 $7.88 $7.86 $7.73 $20595.44 $16148.51 $16148.51
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.47 $-0.52 $-0.58 $-0.62 $-0.61 $-0.62 $-0.55 $-0.53 $-0.58 $-0.54 $-0.53 $-0.45 $-0.59 $-0.52 $-0.56 $-1.49 $-1.40 $-1.52 $-1.82 $-1.17 $-1.17
OCF/Share $-0.47 $-0.52 $-0.58 $-0.62 $-0.61 $-0.62 $-0.55 $-0.53 $-0.58 $-0.54 $-0.53 $-0.45 $-0.59 $-0.52 $-0.56 $-1.49 $-1.40 $-1.52 $-1.82 $-1.17 $-1.17
Cash/Share $1.33 $1.33 $1.61 $1.61 $1.61 $1.59 $1.01 $1.00 $0.98 $0.93 $0.49 $0.45 $0.63 $0.63 $5.24 $8.62 $8.60 $8.45 $9239.73 $7244.70 $6166.28
EBITDA/Share $-0.45 $-0.32 $-0.32 $-0.36 $-0.41 $-0.60 $-0.59 $-0.59 $-0.54 $-0.49 $-0.46 $-0.38 $-0.49 $-0.42 $-1.37 $-2.47 $-2.56 $-2.81 $-2.28 $-2.02 $-2.02
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $23.15 $18.15 $18.15
Net Debt/Share $-1.33 $-1.33 $-1.61 $-1.61 $-1.61 $-1.59 $-1.01 $-1.00 $-0.98 $-0.93 $-0.49 $-0.45 $-0.63 $-0.63 $-5.24 $-8.62 $-8.60 $-8.45 $-9216.58 $-7226.55 $-7226.55
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.381
Altman Z-Prime snapshot only 4.516
Piotroski F-Score 1 1 1 1 1 1 1 1 1 1 1 2 3 3 4 4 4 4 5 4 4
Beneish M-Score
Ohlson O-Score snapshot only -12.777
ROIC (Greenblatt) snapshot only -0.01%
Net-Net WC snapshot only $16118.64
EVA snapshot only $-7629671302.29
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 89.00 89.00 89.00 89.00 89.00 89.00 76.78 76.20 73.86 54.30 64.16 89.00 70.45 89.00 89.00 89.00 89.00 89.00 49.07 48.78 48.784
Credit Grade snapshot only 11
Credit Trend snapshot only -40.216
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 46
Sector Credit Rank snapshot only 41

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms